PMA

P780006: AMERSHAM AFP

FDA PMA · KIT, TEST, ALPHA-FETOPROTEIN FOR NEURAL TUBE DEFECTS · Ortho Clinical Diagnostics

Key facts

PMA number P780006
Trade name AMERSHAM AFP
Generic name KIT, TEST, ALPHA-FETOPROTEIN FOR NEURAL TUBE DEFECTS
Applicant Ortho Clinical Diagnostics
Owner/operator QuidelOrtho Corporation
Product code LOK
Approval date Jun 7, 1984
Docket number 84M-0227
Notice date Jul 6, 1984
Establishment registration 1319681
FEI number 1000136573

At a glance

  • 1–9 Supplements
  • Sep 26, 1989 Latest supplement decision
  • Yes Withdrawn
  • No Summary of safety and effectiveness on file
  • None UDI device identifiers (GUDID)
  • None MAUDE adverse event reports
  • None Recall events

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About PMA approvals

Premarket approval (PMA) is the FDA's most stringent review pathway, required for most Class III devices that support or sustain life or present a potentially unreasonable risk.

Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date:

Browse all PMA approvals